SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Paul Moerman who wrote (27340)1/11/1999 1:48:00 PM
From: Andrew Cooke  Respond to of 32384
 
To all: [slightly off-topic] Does anyone on the thread know much about pharm and biotech use trends for CROs? For example, does Ligand use CROs? Have met an individual from QTRN who implied that their CRO business is growing extremely well. ANy thoughts from this erudite thread? Thanks.



To: Paul Moerman who wrote (27340)1/11/1999 3:53:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
I believe that LGND will be presenting at H&Q in the Grand Ballroom tonight, after the close. Price and volume increasing before the close.



To: Paul Moerman who wrote (27340)1/11/1999 4:44:00 PM
From: LLCF  Respond to of 32384
 
<Henry and thread: I just opened the Jan 8 Kiplinger Washingon Letter and there's an insert (Personal Finance Advisor) giving favorable mention to Chiron, Ligand, and Pathogenesis as companies to consider in the biotech field! >

Hey, Elvis is dead!!!

DAK

Just a joke guy